Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Investigation of the Vanguard™ Complete Knee System
This study is enrolling participants by invitation only.
Study NCT00698854   Information provided by Biomet, Inc.
First Received: June 13, 2008   Last Updated: April 28, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

June 13, 2008
April 28, 2009
March 2004
Knee Society Score [ Time Frame: 6 weeks, 6 months, 1 year, 3 years, 5 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00698854 on ClinicalTrials.gov Archive Site
X-rays [ Time Frame: 6 months, 1 year, 3 years, 5 years ] [ Designated as safety issue: No ]
Same as current
 
A Clinical Investigation of the Vanguard™ Complete Knee System
A Prospective, Non-Controlled, Clinical Investigation of the Vanguard™ Complete Knee System

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.

This is a 5-year prospective observational data collection on the Vanguard Total Knee system. Patients are asked to come in for a preop, operative, impo, 6 Month, 1 Year, 3 Year, & 5 Year visit to check on the function, range of motion, and radiographic assessment of their total knee device.

The Vanguard Knee is an FDA cleared device, and has been on the market since 2004.

 
Observational
Cohort, Prospective
  • Osteoarthritis
  • Traumatic Arthritis
  • Rheumatoid Arthritis
 
Vanguard™ Complete Knee System
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Enrolling by invitation
600
December 2013
December 2013   (final data collection date for primary outcome measure)

Inclusion criteria:

  • Painful and disabled knee joint resulting from osteoarthritis
  • Rheumatoid arthritis
  • Traumatic arthritis where one or more compartments are involved.
  • Correction of varus, valgus, or posttraumatic deformity.
  • Correction or revision of unsuccessful osteotomy, or arthrodesis.

Patient selection factors to be considered include:

  • Need to obtain pain relief and improve function
  • Ability and willingness of the patient to follow instructions
  • Including control of weight and activity level
  • Good nutritional state of the patient
  • Patient must have reached full skeletal maturity.

Exclusion criteria:

Absolute contraindications include:

  • Infection
  • Sepsis
  • Osteomyelitis
  • Failure of a previous joint replacement.

Relative contraindications include:

  • Uncooperative patient or patient with neurologic disorders who are incapable of following directions
  • Osteoporosis
  • Metabolic disorders which may impair bone formation
  • Osteomalacia
  • Distant foci of infections which may spread to the implant site
  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
  • Vascular insufficiency
  • Muscular atrophy
  • Neuromuscular disease
  • Incomplete or deficient soft tissue surrounding the knee.
Both
18 Years and older
No
 
United States
 
 
NCT00698854
Kenneth Beres, MD Director Clinical Research, Biomet Orthopedics, LLC
 
Biomet Orthopedics, LLC
 
Study Director: Kenneth J Beres, MD Clinical Research, Biomet Orthopedics, LLC
Biomet, Inc.
January 2009

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.